PLEASANTON, Calif., April 17, 2023 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the "Company"), a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and life sciences industry, today announced its participation at HIMSS23, the Healthcare Information and Management Systems Society’s Global Health Conference & Exhibition being held in Chicago at McCormick Place, April 17-21, 2023.
Mike Preston, Director of Client Partner Sales at Healthcare Triangle will be joined by Benjamin Cox, Chief Information Officer of CalvertHealth, for a joint presentation titled “Journey to Health Innovation: How to Effectively Implement MEDITECH Backup and DR Solutions on AWS.” The presentation will take place at Amazon Web Services’ Booth # 2056 in Hall A, South Building, on Wednesday, April 19 at 3:30pm CST.
Roy Sookhoo, COO of Healthcare Triangle, commented, “Adopting the public cloud should no longer be viewed as a risk. Rather it should be embraced and seen as a welcome change to help modernize organizations. To fuel this digital transformation, our long-time client CalvertHealth leveraged HCTI’s HITRUST-certified public cloud-powered Data EHR Resiliency solution in combination with Amazon Web Services’ AWS Elastic Disaster Recovery and AWS Backup to strengthen their security posture, while improving performance, efficiency, and reliability. We are excited to join our client at the AWS booth at HIMSS23 for an engaging discussion and audience Q&A.”
HCTI is designated as a “Premier Consulting Partner” and “Top-10 Healthcare Solutions Partner” for AWS.
The HIMSS Global Health Conference & Exhibition is the most influential health information technology event of the year, where 40,000+ professionals throughout the global health ecosystem meet to build relationships during lively networking events, learn from experts in hot topic education sessions and discover innovative health tech products to solve their greatest challenges. To register for HIMSS, please visit here.
About Healthcare Triangle
Healthcare Triangle, Inc. based in Pleasanton, California, reinforces healthcare progress through breakthrough technology and extensive industry knowledge and expertise. We support healthcare providers including hospitals and health systems, payers, and pharma/life sciences organizations in their effort to improve health outcomes. Healthcare Triangle achieves HITRUST Certification for Cloud and Data Platform (CaDP), marketed as CloudEz™ and DataEz™. HITRUST Risk-based, 2-year (r2) Certified status demonstrates to our clients the highest standards for data protection and information security. Healthcare Triangle enables the adoption of new technologies, data enlightenment, business agility, and response to immediate business needs and competitive threats. The highly regulated healthcare and life sciences industries rely on Healthcare Triangle for expertise in digital transformation encompassing the cloud, security and compliance, data lifecycle management, healthcare interoperability, and clinical and business performance optimization. For more information, visit www.healthcaretriangle.com.
Forward-Looking Statements and Safe Harbor Notice
All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate." The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company's Prospectus filed with the SEC on October 7, 2021, previous filings, subsequent filings and future periodic reports filed with the SEC. All of the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.
The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.
Contacts | |
Investors: | 1-800-617-9550, This email address is being protected from spambots. You need JavaScript enabled to view it. |
Media: | Michael Campana, This email address is being protected from spambots. You need JavaScript enabled to view it. |
Last Trade: | US$0.66 |
Daily Change: | 0.02 2.81 |
Daily Volume: | 16,359 |
Market Cap: | US$3.730M |
April 04, 2024 April 03, 2024 March 12, 2024 February 14, 2024 |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB